Rhenman & Partners Asset Management’s Krystal Biotech KRYS Stock Holding History

Rhenman & Partners Asset Management’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.75M	Sell
2025 Q1	$3.2M	Sell
2024 Q4	$3.72M	Buy
2024 Q3	$3.09M	Sell
2024 Q2	$3.49M	Hold
2024 Q1	$3.38M	Buy